Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Fresh Tracks Therapeutics Q3 EPS $0.32 Up From $(2.07) YoY, Sales $7.99M Up From $486.00K YoY

Author: Benzinga Newsdesk | November 13, 2023 09:51am
Fresh Tracks Therapeutics (NASDAQ:FRTX) reported quarterly earnings of $0.32 per share. This is a 115.46 percent increase over losses of $(2.07) per share from the same period last year. The company reported $7.99 million in sales this quarter. This is a 1.54K percent increase over sales of $486.00 thousand the same period last year.

Posted In: FRTX


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist